Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| endothelial cell | 17 studies | 26% ± 10% | |
| astrocyte | 10 studies | 30% ± 15% | |
| microglial cell | 9 studies | 27% ± 10% | |
| fibroblast | 9 studies | 23% ± 6% | |
| ciliated cell | 9 studies | 24% ± 6% | |
| oligodendrocyte | 9 studies | 31% ± 12% | |
| glutamatergic neuron | 8 studies | 41% ± 24% | |
| epithelial cell | 8 studies | 34% ± 18% | |
| adipocyte | 8 studies | 24% ± 6% | |
| basal cell | 8 studies | 26% ± 12% | |
| oligodendrocyte precursor cell | 8 studies | 29% ± 14% | |
| B cell | 7 studies | 22% ± 3% | |
| macrophage | 7 studies | 28% ± 8% | |
| GABAergic neuron | 7 studies | 42% ± 18% | |
| interneuron | 6 studies | 40% ± 22% | |
| pericyte | 6 studies | 22% ± 8% | |
| type I pneumocyte | 6 studies | 20% ± 5% | |
| endothelial cell of lymphatic vessel | 5 studies | 26% ± 7% | |
| type II pneumocyte | 5 studies | 19% ± 4% | |
| dendritic cell | 5 studies | 26% ± 10% | |
| CD4-positive, alpha-beta T cell | 4 studies | 19% ± 2% | |
| hematopoietic precursor cell | 4 studies | 25% ± 10% | |
| myeloid cell | 4 studies | 22% ± 3% | |
| amacrine cell | 4 studies | 21% ± 3% | |
| retina horizontal cell | 4 studies | 21% ± 3% | |
| vein endothelial cell | 4 studies | 24% ± 13% | |
| lymphocyte | 4 studies | 25% ± 6% | |
| muscle cell | 4 studies | 23% ± 8% | |
| club cell | 4 studies | 22% ± 5% | |
| smooth muscle cell | 4 studies | 20% ± 2% | |
| GABAergic interneuron | 3 studies | 22% ± 5% | |
| retinal ganglion cell | 3 studies | 19% ± 1% | |
| plasma cell | 3 studies | 26% ± 13% | |
| glycinergic amacrine cell | 3 studies | 19% ± 0% | |
| retinal rod cell | 3 studies | 18% ± 3% | |
| CD8-positive, alpha-beta T cell | 3 studies | 17% ± 1% | |
| natural killer cell | 3 studies | 19% ± 2% | |
| abnormal cell | 3 studies | 25% ± 13% | |
| neural progenitor cell | 3 studies | 20% ± 7% | |
| T cell | 3 studies | 19% ± 1% | |
| monocyte | 3 studies | 22% ± 2% | |
| goblet cell | 3 studies | 31% ± 18% | |
| transit amplifying cell | 3 studies | 35% ± 21% | |
| granule cell | 3 studies | 22% ± 7% | |
| neuron | 3 studies | 38% ± 9% | |
| naive B cell | 3 studies | 18% ± 2% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| esophagus | 100% | 2413.58 | 1445 / 1445 | 100% | 27.14 | 183 / 183 |
| ovary | 100% | 1934.42 | 180 / 180 | 100% | 14.15 | 430 / 430 |
| lung | 100% | 2053.77 | 577 / 578 | 100% | 20.14 | 1155 / 1155 |
| breast | 100% | 2262.10 | 459 / 459 | 100% | 25.42 | 1116 / 1118 |
| uterus | 100% | 2176.05 | 170 / 170 | 99% | 19.92 | 456 / 459 |
| brain | 99% | 1411.33 | 2625 / 2642 | 100% | 14.72 | 704 / 705 |
| bladder | 100% | 2372.62 | 21 / 21 | 99% | 20.00 | 499 / 504 |
| prostate | 100% | 1813.87 | 245 / 245 | 99% | 14.89 | 497 / 502 |
| pancreas | 100% | 1016.13 | 328 / 328 | 99% | 13.85 | 176 / 178 |
| thymus | 100% | 1732.91 | 653 / 653 | 99% | 12.24 | 596 / 605 |
| stomach | 100% | 1520.69 | 359 / 359 | 98% | 20.60 | 281 / 286 |
| intestine | 100% | 2063.64 | 966 / 966 | 98% | 21.44 | 515 / 527 |
| kidney | 100% | 1261.93 | 89 / 89 | 95% | 12.59 | 859 / 901 |
| skin | 100% | 3239.71 | 1808 / 1809 | 94% | 19.96 | 444 / 472 |
| adrenal gland | 100% | 2005.02 | 258 / 258 | 93% | 10.16 | 214 / 230 |
| liver | 100% | 1176.41 | 225 / 226 | 85% | 7.39 | 344 / 406 |
| adipose | 100% | 2423.73 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 100% | 1977.84 | 1335 / 1335 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 19.63 | 29 / 29 |
| muscle | 100% | 3034.20 | 803 / 803 | 0% | 0 | 0 / 0 |
| spleen | 100% | 1759.92 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 21.07 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 7.48 | 1 / 1 |
| heart | 95% | 1746.42 | 821 / 861 | 0% | 0 | 0 / 0 |
| peripheral blood | 69% | 1854.20 | 641 / 929 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 63% | 6.53 | 50 / 80 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0001525 | Biological process | angiogenesis |
| GO_0006474 | Biological process | N-terminal protein amino acid acetylation |
| GO_0017196 | Biological process | N-terminal peptidyl-methionine acetylation |
| GO_0043066 | Biological process | negative regulation of apoptotic process |
| GO_0045893 | Biological process | positive regulation of DNA-templated transcription |
| GO_0030154 | Biological process | cell differentiation |
| GO_0050821 | Biological process | protein stabilization |
| GO_0016020 | Cellular component | membrane |
| GO_0016604 | Cellular component | nuclear body |
| GO_0005829 | Cellular component | cytosol |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0043231 | Cellular component | intracellular membrane-bounded organelle |
| GO_0031415 | Cellular component | NatA complex |
| GO_0005667 | Cellular component | transcription regulator complex |
| GO_0005634 | Cellular component | nucleus |
| GO_0043022 | Molecular function | ribosome binding |
| GO_0016407 | Molecular function | acetyltransferase activity |
| GO_0003723 | Molecular function | RNA binding |
| GO_0005515 | Molecular function | protein binding |
| Gene name | NAA15 |
| Protein name | N-alpha-acetyltransferase 15, NatA auxiliary subunit N-alpha-acetyltransferase 15, NatA auxiliary subunit (Gastric cancer antigen Ga19) (N-terminal acetyltransferase) (NMDA receptor-regulated protein 1) (Protein tubedown-1) (Tbdn100) |
| Synonyms | TBDN100 NARG1 NATH GA19 |
| Description | FUNCTION: Auxillary subunit of N-terminal acetyltransferase complexes which display alpha (N-terminal) acetyltransferase (NAT) activity . The NAT activity may be important for vascular, hematopoietic and neuronal growth and development . Required to control retinal neovascularization in adult ocular endothelial cells . In complex with XRCC6 and XRCC5 (Ku80), up-regulates transcription from the osteocalcin promoter . . |
| Accessions | A0A8V8TQ00 ENST00000700280.1 ENST00000398947.1 ENST00000296543.10 [Q9BXJ9-1] D6RAP7 ENST00000468029.2 A0A8V8TR41 A0A8V8TQ34 A0A8V8TPI7 Q9BXJ9 ENST00000700276.1 A0A0B4J1W3 ENST00000515576.1 ENST00000700277.1 A0A8V8TQT7 ENST00000700275.1 |